Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.
The item "FCFE-Dividend-Plus-Stock-Repurchases-Coverage" stands at 0.715 as of 09/30/2025.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "FCFE Dividend Plus Stock Repurchases Coverage" stands at 0.715. This represents an increase of 309.67 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -58.05 percent compared to the value the year prior.
The 1 year change in percent is -58.05.
The 3 year change in percent is -54.78.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - FCFE Dividend Plus Stock Repurchases Coverage | 905,699,262,464.00 |
![]() | Johnson & Johnson - FCFE Dividend Plus Stock Repurchases Coverage | 486,508,953,600.00 |
![]() | AbbVie Inc - FCFE Dividend Plus Stock Repurchases Coverage | 399,570,305,024.00 |
![]() | Roche Holding AG - FCFE Dividend Plus Stock Repurchases Coverage | 317,433,206,677.55 |
![]() | AstraZeneca PLC - FCFE Dividend Plus Stock Repurchases Coverage | 280,205,508,085.11 |